Omee-D Capsule is a combination pharmaceutical formulation containing Domperidone 10 mg and Omeprazole 20 mg, designed to manage gastrointestinal disorders characterized by acid reflux and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Omeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, providing effective relief from acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The synergistic action of these two agents in Omee-D Capsule offers both symptomatic relief and promotes mucosal healing by reducing acid load and improving gastric motility. This combination is particularly beneficial in patients experiencing delayed gastric emptying alongside acid reflux symptoms. Omee-D Capsule should be administered as prescribed by a healthcare professional, with attention to contraindications such as known hypersensitivity to either component, and caution in patients with cardiac arrhythmias or hepatic impairment. Regular monitoring is advised to ensure therapeutic efficacy and minimize potential adverse effects.